Principal Financial Group Inc. Sells 2,005 Shares of Chemed Corp. (CHE)
Principal Financial Group Inc. decreased its position in shares of Chemed Corp. (NYSE:CHE) by 1.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 131,227 shares of the company’s stock after selling 2,005 shares during the period. Principal Financial Group Inc. owned 0.82% of Chemed Corp. worth $26,515,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CHE. Acrospire Investment Management LLC bought a new stake in Chemed Corp. during the 2nd quarter worth approximately $120,000. Pacad Investment Ltd. raised its stake in Chemed Corp. by 250.0% during the 2nd quarter. Pacad Investment Ltd. now owns 700 shares of the company’s stock worth $143,000 after acquiring an additional 500 shares during the period. IFP Advisors Inc raised its stake in Chemed Corp. by 1,504.5% during the 3rd quarter. IFP Advisors Inc now owns 706 shares of the company’s stock worth $143,000 after acquiring an additional 662 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Chemed Corp. by 12.8% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 731 shares of the company’s stock worth $150,000 after acquiring an additional 83 shares during the period. Finally, MCF Advisors LLC bought a new stake in Chemed Corp. during the 3rd quarter worth approximately $152,000. Institutional investors own 96.50% of the company’s stock.
In other news, CEO Kevin J. Mcnamara sold 10,000 shares of Chemed Corp. stock in a transaction that occurred on Tuesday, October 31st. The shares were sold at an average price of $223.42, for a total transaction of $2,234,200.00. Following the sale, the chief executive officer now owns 170,016 shares in the company, valued at $37,984,974.72. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Donald E. Saunders sold 500 shares of Chemed Corp. stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $227.75, for a total transaction of $113,875.00. Following the sale, the director now owns 10,298 shares in the company, valued at approximately $2,345,369.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,229 shares of company stock worth $7,556,478. Company insiders own 4.90% of the company’s stock.
A number of research firms have commented on CHE. Oppenheimer Holdings, Inc. raised their target price on shares of Chemed Corp. from $220.00 to $225.00 and gave the stock an “outperform” rating in a research note on Friday, October 27th. National Bank Financial upgraded shares of Chemed Corp. from a “sector perform market weight” rating to an “outperform market weight” rating in a research note on Sunday, August 13th. Zacks Investment Research cut shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, September 13th. BidaskClub cut shares of Chemed Corp. from a “buy” rating to a “hold” rating in a research note on Wednesday, August 2nd. Finally, Royal Bank Of Canada restated a “hold” rating and set a $209.00 target price on shares of Chemed Corp. in a research note on Monday, July 31st. Three analysts have rated the stock with a hold rating and two have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus price target of $236.00.
Shares of Chemed Corp. (NYSE CHE) opened at $231.61 on Monday. The stock has a market cap of $3,697.89, a P/E ratio of 28.52, a PEG ratio of 4.90 and a beta of 1.14. The company has a current ratio of 0.50, a quick ratio of 0.48 and a debt-to-equity ratio of 0.15. Chemed Corp. has a 1 year low of $145.35 and a 1 year high of $235.96.
Chemed Corp. (NYSE:CHE) last released its quarterly earnings data on Thursday, October 26th. The company reported $2.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.00 by $0.15. The firm had revenue of $417.40 million for the quarter, compared to analysts’ expectations of $414.34 million. Chemed Corp. had a net margin of 4.62% and a return on equity of 27.69%. The company’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.73 earnings per share. sell-side analysts expect that Chemed Corp. will post 4.73 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 4th. Stockholders of record on Monday, November 13th will be given a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 0.48%. The ex-dividend date is Friday, November 10th. Chemed Corp.’s payout ratio is currently 24.89%.
Chemed Corp. Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.